FindTrial
Sign In

A scientific study to know the effect of Vitamin D supplementation on CD4 count in newly diagnosed ART eligible HIV infected & Vitamin D deficient patients.

Double blind, parallel group Randomised placebo controlled trial to study the effect of Vitamin D supplementation on CD4 count in newly diagnosed ART eligible HIV infected & Vitamin D deficient patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/01/011489
Enrollment
80
Registered
2018-01-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- hiv infected and vitamin D deficient patients

Interventions

Intervention1: vitamin D 60000 iu: orally once weekly for 8 week followed by once per month for another 4 months Control Intervention1: placebo: orally once weekly for 8 week followed by once per mont

Sponsors

Jagannath de
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: newly diagnosed hiv infected and ART eligible patients as per NACO guidline and vitamine D deficient. vitamine D deficiency define as vitamin D level below 20 ng/ml

Exclusion criteria

Exclusion criteria: any prior documented chronic kidney disease and chronic liver disease

Design outcomes

Primary

MeasureTime frame
change in CD4 count at the end of 6 months.Timepoint: 6 months—

Secondary

MeasureTime frame
vitamin D sufficiency achived or not at the end of 6 monthsTimepoint: 6 months—

Countries

India

Contacts

Public ContactJagannath De

IPGMER SSKM Hospital

shantasil@yahoo.co.in9830784234

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026